ResearcherShinshu UniversityNo recent work listed
Kôji Kubota
Matched on ORCID iD 0000-0003-0164-7685; OpenAlex author ID A5037231478. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 5
2021: 1 paper · 2022: 2 papers · 2023: 1 paper
Papers 4
- Increased mitochondria are responsible for the acquisition of gemcitabine resistance in pancreatic cancer cell lines. First author DOI 10.1111/cas.15962↗
- Preoperative Peripheral Blood Lymphocyte-to-Monocyte Ratio Predicts Long-Term Outcome for Patients with Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1245/s10434-021-10848-8↗
- ASO Author Reflections: Lymphocyte-to-monocyte ratio as prognostic biomarker in pancreatic ductal adenocarcinoma. Co-author DOI 10.1245/s10434-021-10879-1↗
- Lymphoepithelial cyst mimicking pancreatic cancer: a case report and literature review. Co-author DOI 10.1186/s40792-021-01191-x↗
Closest collaborators
The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yuji Soejima · 4 shared papers, 2021–2023 · strength 0.71
- Paper ASO Author Reflections: Lymphocyte-to-monocyte ratio as prognostic biomarker in pancreatic ductal adenocarcinoma. DOI 10.1245/s10434-021-10879-1↗
- Paper Increased mitochondria are responsible for the acquisition of gemcitabine resistance in pancreatic cancer cell lines. DOI 10.1111/cas.15962↗
- Paper Preoperative Peripheral Blood Lymphocyte-to-Monocyte Ratio Predicts Long-Term Outcome for Patients with Pancreatic Duct… DOI 10.1245/s10434-021-10848-8↗
- Hitoshi Masuo · 2 shared papers, 2022–2023 · strength 0.32
- Paper Increased mitochondria are responsible for the acquisition of gemcitabine resistance in pancreatic cancer cell lines. DOI 10.1111/cas.15962↗
- Paper Preoperative Peripheral Blood Lymphocyte-to-Monocyte Ratio Predicts Long-Term Outcome for Patients with Pancreatic Duct… DOI 10.1245/s10434-021-10848-8↗
- Satoru Miyazaki · 1 shared paper, 2023 · strength 0.18
- Kentaro Umemura · 1 shared paper, 2022 · strength 0.14
- Takuya Iguchi · 1 shared paper, 2021 · strength 0.13
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.